Warren Dsouza currently serves as the Executive Director and Head of Search and Evaluation at Exelixis, where he plays a pivotal role in advancing the company's strategic initiatives in drug development, particularly within the oncology and immuno-oncology sectors. With a robust background in discovery research...
Warren Dsouza currently serves as the Executive Director and Head of Search and Evaluation at Exelixis, where he plays a pivotal role in advancing the company's strategic initiatives in drug development, particularly within the oncology and immuno-oncology sectors. With a robust background in discovery research and business development, Warren is adept at identifying and evaluating innovative therapeutic candidates that align with Exelixis's mission to improve patient outcomes. His expertise spans a wide array of specialties, including autoimmunity, inflammation, and microbiome research, which positions him uniquely to explore novel treatment avenues.
At Exelixis, Warren leads key projects that focus on the integration of cutting-edge technologies and methodologies, such as flow cytometry and in vitro assay development, to drive biomarker discovery and enhance drug efficacy. His deep understanding of monoclonal antibodies and immunoassays allows him to assess potential partnerships and collaborations that can accelerate the development of next-generation therapies. Under his leadership, the Search and Evaluation team has successfully identified promising candidates that have the potential to address unmet medical needs in oncology and related fields.
Warren's commitment to advancing scientific innovation is evident in his collaborative approach, working closely with cross-functional teams to ensure that the strategic direction aligns with the latest advancements in life sciences. His insights into the complexities of drug development, coupled with his passion for improving patient care, make him a key asset to Exelixis and the broader biopharmaceutical community.
